|Articles|February 19, 2016
Translational Medicine: A “Team Sport”?
Author(s)DIA
February 19, 2016
Advertisement
Dr. Makoto Suematsu, President of the Japan Agency for Medical Research & Development (AMED); and Dr. Christopher P. Austin, Director of the National Center for Advancing Translational Sciences (NCATS), US National Institutes of Health; discuss how collaboration between their agencies will ultimately deliver better therapies more quickly to more patients.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
4
The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels
5